Incretins are gastrointestinal‐derived hormones released in response to a meal playing a
key role in the regulation of postprandial secretion of insulin (incretin effect) and glucagon by …

The global obesity epidemic fuelled by our obesogenic environment, and the prevention and
treatment of obesity are some of the most important health-care challenges of our time …

Incretins are hormones secreted from enteroendocrine cells after nutrient intake that
stimulate insulin secretion from β cells in a glucose‐dependent manner. Glucose …

The incretin hormones glucagon‐like‐peptide‐1 (GLP‐1) and glucose‐dependent
insulinotropic polypeptide (GIP) are released from the intestine following oral ingestion of …

Incretin-based therapies exploit the insulinotropic actions of the gut hormones gastric
inhibitory peptide (GIP) and glucagon-like peptide-1 (GLP-1) for the treatment of diabetes …

The prevalence of obesity continues to grow rapidly worldwide, posing many public health
challenges of the 21st century. Obese subjects are at major risk for serious diet-related …

This review focuses on the mechanisms regulating the synthesis, secretion, biological
actions, and therapeutic relevance of the incretin peptides glucose-dependent insulinotropic …

Incretins are gut hormones that are secreted from enteroendocrine cells into the blood within
minutes after eating. One of their many physiological roles is to regulate the amount of …

The incretin hormone glucagon-like peptide-1 (GLP-1) has received enormous attention
during the past three decades as a therapeutic target for the treatment of obesity and type 2 …

Incretin hormones, principally glucose-dependent insulinotropic polypeptide (GIP) and
glucagon-like peptide-1 (GLP-1), potentiate meal-stimulated insulin secretion through direct …